Immunotherapy targeting glioma stem cells – insights and perspectives
Authors:
- 26 December 2011
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Biological Therapy
- Vol. 12 (2) , 165-178
Abstract
(2012). Immunotherapy targeting glioma stem cells – insights and perspectives. Expert Opinion on Biological Therapy: Vol. 12, No. 2, pp. 165-178.Keywords
This publication has 104 references indexed in Scilit:
- Glioma Stem Cell Research for the Development of ImmunotherapyNeurosurgery Clinics of North America, 2009
- Targeting Interleukin 6 Signaling Suppresses Glioma Stem Cell Survival and Tumor GrowthStem Cells, 2009
- Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer ModelCell, 2009
- The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cellsJournal of Molecular Medicine, 2008
- ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical OutcomeCell Stem Cell, 2007
- Interleukin-6 gene amplification and shortened survival in glioblastoma patientsBritish Journal of Cancer, 2007
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006
- De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signallingNature, 2004
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences, 2003
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997